Source link : https://newshealth.biz/health-news/blockbuster-drug-gets-breast-cancer-approvals-in-curative-setting/
The FDA on Friday approved two new trastuzumab deruxtecan (T-DXd; Enhertu) indications for treating early-stage breast cancer patients with HER2-positive disease. In the neoadjuvant setting, the first indication is for stage II-III tumors and covers treatment with T-DXd followed by a taxane, trastuzumab (Herceptin), and pertuzumab (Perjeta), or THP. And in the adjuvant setting, the […]
The post Blockbuster Drug Gets Breast Cancer Approvals in Curative Setting first appeared on News Health.
—-
Author : News Health
Publish date : 2026-05-18 18:53:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8